Targeting B-cell lymphoma 6 (BCL6) for the treatment of diffuse large B-cell lymphomas (DLBCLs)

被引：0

作者：

Cardenas, Mariano ^{[2
]}

Yu, Wenbo ^{[1
]}

Zhu, Shilei ^{[1
]}

Cerchietti, Leandro C. ^{[2
]}

Melnick, Ari ^{[2
]}

MacKerell, Alexander D., Jr. ^{[1
]}

Xue, Fengtian ^{[1
]}

机构：

[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA

[2] Cornell Univ, Dept Pharmacol, New York, NY 10065 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

318-MEDI

引用

页数：1

共 50 条

[21] Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
Kramer, MHH
Hermans, J
Wijburg, E
Philippo, K
Geelen, E
van Krieken, JHJM
de Jong, D
Maartense, E
Schuuring, E
Kluin, PM
BLOOD, 1998, 92 (09) : 3152 - 3162
[22] Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma
Kurtz, David M.
Scherer, Florian
Newman, Aaron M.
Craig, Alexander
Jin, Michael
Stehr, Henning
Chabon, Jacob J.
Esfahani, Mohammad
Liu, Chih Long
Zhou, Li
Glover, Cynthia
Visser, Brendan C.
Poultsides, George
Advani, Ranjana H.
Maeda, Lauren S.
Gupta, Neel K.
Levy, Ronald
Ohgami, Robert S.
Davis, R. Eric
Kunder, Christian A.
Westin, Jason R.
Diehn, Maximilian
Alizadeh, Ash A.
BLOOD, 2016, 128 (22)
[23] Arsenic trioxide targets BCL6 oncoprotein for degradation in BCL6-dependent diffuse large B-cell lymphoma
Yue, Lok Man
Chau, David Hau Wing
Piao, Wenying
Tse, Wai Choi
Kwong, Yok Lam
CANCER RESEARCH, 2017, 77
[24] BCL2, BCL6 and CMYC abnormalities in 44 Turkish patients with diffuse large B-cell lymphomas
Kahraman, D. Solakoglu
Diniz, G.
Koca, Y.
Ekmekci, S.
Ceylan, C.
VIRCHOWS ARCHIV, 2017, 471 : S142 - S142
[25] Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
McCoull, William
Cheung, Tony
Anderson, Erica
Barton, Peter
Burgess, Jonathan
Byth, Kate
Cao, Qing
Castald, M. Paola
Chen, Huawei
Chiarparin, Elisabetta
Carbajo, Rodrigo J.
Code, Erin
Cowan, Suzanna
Davey, Paul R.
Ferguson, Andrew D.
Fillery, Shaun
Fuller, Nathan O.
Gao, Ning
Hargreaves, David
Howard, Martin R.
Hu, Jun
Kawatkar, Aarti
Kemmitt, Paul D.
Leo, Elisabetta
Molina, Daniel M.
O'Conne', Nichole
Petteruti, Philip
Rasmusson, Timothy
Raubo, Piotr
Rawlins, Philip B.
Ricchiuto, Piero
Robb, Graeme R.
Schenone, Monica
Waring, Michael J.
Zinda, Michael
Fawell, Stephen
Wilson, David M.
ACS CHEMICAL BIOLOGY, 2018, 13 (11) : 3131 - 3141
[26] A mouse model of diffuse large B-cell lymphoma induced by deregulated BCL6 expression.
Cattoretti, G
Pasqualucci, L
Ballon, G
Tam, W
Murty, VV
Morse, HC
Dalla-Favera, R
BLOOD, 2003, 102 (11) : 136A - 136A
[27] Prognostic importance of BCL6 rearrangements in diffuse large B-cell Lymphoma with respect to BCL6 protein levels and primary lymphoma site Reply
Tibiletti, Maria Grazia
Uccella, Silvia
Capella, Carlo
HUMAN PATHOLOGY, 2009, 40 (07) : 1056 - 1056
[28] Genomic organisation and expression of BCL6 in murine B-cell lymphomas
Qi, CF
Hori, M
Coleman, AE
Torrey, TA
Taddesse-Heath, L
Ye, BH
Chattopadhyay, SK
Hartley, JW
Morse, HC
LEUKEMIA RESEARCH, 2000, 24 (08) : 719 - 732
[29] The Bcl6 locus is not mutated in mouse B-cell lineage lymphomas
Hori, M
Qi, CF
Torrey, TA
Huppi, K
Morse, HC
LEUKEMIA RESEARCH, 2002, 26 (08) : 739 - 743
[30] B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas
Gu, Haijun
He, Jia
Li, Yuzhan
Mi, Dazhao
Guan, Tian
Guo, Weikai
Liu, Bo
Chen, Yihua
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (23) : 15559 - 15583

← 1 2 3 4 5 →